RecruitingNCT05964660

Echocardiography-based Motion Integration and Management for Substrate Characterization and STAR Therapy in Ventricular Tachycardias

New 3D-echocardiography-based Motion Integration and mAnagement for subsTrate characteRisation and Stereotactic Arrhythmia radIoablation tX in Ventricular Tachycardias- the MATRIX-VT Study


Sponsor

University of Luebeck

Enrollment

20 participants

Start Date

Aug 14, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Prospective, observational, single center, pilot study to analyze the feasibility of motion and structural data integration in patients with ventricular arrhythmia by means of artificial intelligence for improved arrhythmogenic substrate characterization and motion management during stereotactic arrhythmia radioablation.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Inclusion Criteria3

  • Age ≥ 18 years
  • Indication for catheter ablation of ventricular arrhythmias (ventricular fibrillation, ventricular tachycardia, premature ventricular contractions)
  • Indication for preprocedural contrast-enhanced cardiac computed tomography for cardiac structure characterization

Exclusion Criteria2

  • Platelet count < 100,000 cells/mm3
  • BMI > 45 kg/m2 or < 18 kg/m2

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Klinik für Rhythmologie

Lübeck, Schleswig-Holstein, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05964660


Related Trials